KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)

Anti-EGFR therapy appears to be a potential treatment option for squamous cell anal carcinoma (SCAC). KRAS mutation is a rare event in SCAC, indicating the absence of the principal mechanism of resistance to this type of therapy. However, no information is available from the literature regarding the...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadei Gardini, Andrea, Capelli, Laura, Ulivi, Paola, Giannini, Massimo, Freier, Eva, Tamberi, Stefano, Scarpi, Emanuela, Passardi, Alassandro, Zoli, Wainer, Ragazzini, Angela, Amadori, Dino, Frassineti, Giovanni Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958420/
https://www.ncbi.nlm.nih.gov/pubmed/24642661
http://dx.doi.org/10.1371/journal.pone.0092071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958420/
https://www.ncbi.nlm.nih.gov/pubmed/24642661
http://dx.doi.org/10.1371/journal.pone.0092071

Ejemplares similares